| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |